| アブストラクト | Genital warts, 90% of which are caused by human papillomavirus types 6 and 11, are a significant problem in the UK. The cost of managing genital warts was previously estimated at pound52.4 million for 2010. The objective of this study was to estimate the cost of genital warts management up to 2012 in the UK and by jurisdiction. Population statistics and the number of reported genital warts cases in genito-urinary medicine clinics were obtained and extrapolated to 2012. Cases of genital warts treated in primary care were estimated from The Health Improvement Network database. The number of visits and therapy required were estimated by genito-urinary medicine experts. Costs were obtained from the appropriate national tariffs. The model estimated there were 220,875 genital warts cases in the UK in 2012, costing pound58.44 million ( pound265/patient). It estimated 157,793 cases in England costing pound41.74 million; 7468 cases in Scotland costing pound1.90 million; 7095 cases in Wales costing pound1.87 million; and 3621 cases in Northern Ireland costing pound948,000. The full National Health Service costs for the management of genital warts have never previously been estimated separately for each jurisdiction. Findings reveal a significant economic burden, which is important to quantify when understanding the value of quadrivalent human papilloma virus vaccination. |
|---|
| ジャーナル名 | International journal of STD & AIDS |
|---|
| Pubmed追加日 | 2015/02/15 |
|---|
| 投稿者 | Coles, V A H; Chapman, R; Lanitis, T; Carroll, S M |
|---|
| 組織名 | Sanofi Pasteur MSD, Maidenhead, UK vcoles@spmsd.com.;Evidera, London, UK.;Sanofi Pasteur MSD, Maidenhead, UK. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/25681263/ |
|---|
